The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Funding from the National Institutes of Health (NIH) generated $94.15 billion in economic activity and supported 390,863 jobs in 2025, according to a ...

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

In 2025 it seemed the only certainty for biotech was more uncertainty. Biotech leaders conducted business as usual against the background of ongoing funding challenges and ever-increasing drug ...

Tomorrow BioTech and The Super Crowd join forces to give biotech startups labs, crowdfunding, and capital to turn ...

The biotechnology sector’s foundations rest on basic scientific research. Early experiments done in academic laboratories often yield the discoveries that venture investors later form drug startups ...

Slate Medicines, a new Raleigh biotechnology company developing treatments for migraine and headache disorders, has announced ...

"We are also seeing improvement in US biotech funding, as well as higher M&A and IPO activity, which are leading indicators ...

For full-year 2025, 58 biotech deals worth $65.9 billion were completed compared with 73 deals worth $109 billion in all of 2024. This represents a major decline in total dollar volume and the number ...

Tevogen Bio announced Jan. 28 it entered an agreement with KRHP LLC. The accord means the Warren-headquartered clinical-stage specialty immunotherapy biotechnology company, which NJBIZ has previously ...

A New Orleans-based biotech company has developed a breakthrough non-opioid pain medication, which is backed by funding from Ochsner Ventures, the investment arm of Ochsner Health, and from Gulf South ...